A 3D tissue model-on-a-chip for studying the effects of human senescent fibroblasts on blood vessels. (11th November 2020)

• Record Type: Journal Article
• Authors: Pauty, Joris; Nakano, Shizuka; Usuba, Ryo; Nakajima, Tadaaki; Johmura, Yoshikazu; Omori, Satotaka; Sakamoto, Naoya; Kikuchi, Akihiko; Nakanishi, Makoto; Matsunaga, Yukiko T.
• Is Part Of: Biomaterials science. Volume 9:Number 1(2021)
• Page Start: 199
• Page End: 211
• Publication Date: 2020-11-11
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d0bm01297a
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Senescent cells modify their environment and cause tissue aging that leads to organ dysfunction. Developing strategies for healthy aging rises a need for in vitro models that enables to study senescence and senotherapeutics at a tissue level. Abstract : All human tissues experience aging that eventually causes organ dysfunction and disease. Cellular senescence was discovered in fibroblasts cultured in vitro. In adults, it is a primary defense mechanism against cancer, but also a major contributor to lifespan limits and disorders associated with aging. To assess how human blood vessels change in an aged environment, we developed an elementary tissue model-on-a-chip that comprises an in vitro three-dimensional model of a blood vessel embedded in a collagen gel with young or senescent skin fibroblasts. We found that senescent fibroblasts mechanically altered the surrounding extracellular matrix by exerting excessive traction stress. We then found that senescent fibroblasts induced sprouting angiogenesis of a microvessel via their senescence-associated secretory phenotype (SASP). Finally, we gathered evidence that the mechanical changes of the microenvironment play a role in sustaining SASP-induced angiogenesis. The model proved useful in monitoring morphological changes in blood vessels induced by senescent fibroblasts while controlling the proportion of senescent cells, and enabled the study of SASP inhibitors, a class of drugs useful in aging and cancer research.